STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells-Reference-Cited by-同舟云学术

STAT3 inhibition by STA21 increases cell surface expression of MICB and the release of soluble MICB by gastric adenocarcinoma cells

Published:2017-11 Issue:11 Volume:222 Page:1043-1051
ISSN:0171-2985
Container-title:Immunobiology
language:en
Short-container-title:Immunobiology

Author:

Garrido-Tapia Macarena,Hernández Carolina J.,Ascui Gabriel,Kramm Karina,Morales Marcela,Gárate Valentina,Zúñiga Roberto,Bustamante Marco,Aguillón Juan Carlos,Catalán Diego,Ribeiro Carolina H.,Molina María Carmen

Publisher

Elsevier BV

Subject

Hematology,Immunology,Immunology and Allergy

Reference41 articles.

1. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA;Bauer;Science,1999

2. Novel role for STAT3 in transcriptional regulation of NK immune cell targeting receptor MICA on cancer cells;Bedel;Cancer Res.,2011

3. Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer;Bharadwaj;Oncogene,2015

4. Cutting edge: the metalloproteinase ADAM17/TNF-alpha-converting enzyme regulates proteolytic shedding of the MHC class I-related chain B protein;Boutet;J. Immunol.,2009

5. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the a disintegrin and metalloproteases 10 and 17;Chitadze;Int. J. Cancer,2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In-depth analysis of the interplay between oncogenic mutations and NK cell-mediated cancer surveillance in solid tumors;OncoImmunology;2024-07-18

2. A genetic variant in the TAPBP gene enhances cervical cancer susceptibility by increasing m6A modification;Archives of Toxicology;2024-07-12

3. The emerging role of glycolysis and immune evasion in gastric cancer;Cancer Cell International;2023-12-09

4. Targeting the STAT3 oncogenic pathway: Cancer immunotherapy and drug repurposing;Biomedicine & Pharmacotherapy;2023-11

5. Oridonin enhances cytotoxic activity of natural killer cells against lung cancer;International Immunopharmacology;2023-09